Modern Technique Ensures mRNA Vaccine Integrity with Laser Technology

Messenger RNA (mRNA) technology is revolutionizing medicine, offering a way to instruct our cells to produce proteins that can prevent or fight diseases like cancer and infectious illnesses. However, the effectiveness of mRNA therapies hinges on their stability and successful delivery into cells. Researchers are continually seeking ways to optimize the encapsulation of mRNA within protective carriers, known as lipid nanoparticles.

Ensuring Proper mRNA Encapsulation

Before mRNA can exert its therapeutic effect, it must be packaged into lipid nanoparticles (LNPs) to shield it from rapid degradation within the body. These fatty bubbles act as a delivery system, facilitating the mRNA’s entry into cells to deliver instructions for protein production. A key challenge lies in verifying that the mRNA is correctly and completely encapsulated within these nanoparticles.

Researchers at the University at Albany, SUNY, are developing a new technique utilizing Raman spectroscopy – a non-destructive laser method that analyzes the chemical composition of materials – to determine if mRNA is properly encapsulated inside lipid nanoparticles. Their findings, recently published in Analytical Chemistry, demonstrate the potential of this method for rapid evaluation of mRNA vaccine and therapeutic integrity.

How Raman Spectroscopy Works

“mRNA therapeutics have emerged as a powerful tool for treating a wide range of diseases, but their clinical success depends on overcoming issues of instability and delivery,” said UAlbany chemist Igor Lednev, who leads the technique’s development. “Raman spectroscopy offers us unique information that can help to ensure mRNA is fully encapsulated inside lipid nanoparticles, ensuring the safety and effectiveness of these therapeutics.”

Raman spectroscopy functions by directing a laser light onto a sample and measuring the scattered radiation. The resulting scattered light pattern is unique to each sample, acting as a chemical “fingerprint.” Unlike current methods that often require breaking apart vaccine samples – a process that is both destructive and time-consuming – this technique is instantaneous and preserves the sample for further testing.

“Intact lipid nanoparticles are not very stable and are difficult to characterize by existing techniques. Raman spectroscopy allows us to analyze mRNA inside lipid nanoparticles without damaging it. This means we can optimize formulations to improve both safety and effectiveness,” explains Alexander Shekhtman, professor in UAlbany’s Department of Chemistry and researcher at the RNA Institute.

Overcoming Detection Challenges with Deep-UV Raman

Because the amount of mRNA is slight compared to the surrounding lipid nanoparticles, detecting it with conventional Raman spectroscopy can be difficult. To address this, the research team employs a specialized deep ultraviolet (deep-UV) Raman instrument developed in Lednev’s lab. The deep-UV laser enhances the detection of mRNA molecules while minimizing interference from the lipid nanoparticles.

“We are using our homebuilt instrument to directly analyze mRNA molecules in vaccine samples,” Lednev said. “Combining this with advanced statistical analysis, we have created a quantitative method for ensuring the mRNA is properly protected in lipid nanoparticles.”

Supporting Medicine Development and Future Applications

Lednev has a long history of pioneering the use of Raman spectroscopy, combined with machine learning, for forensic science and medical diagnostics. His previous work includes developing methods for identifying biological stains, gunshot residue, and trace evidence, as well as non-invasive diagnostics for neurodegenerative diseases like Alzheimer’s.

He envisions that this technique could be implemented in quality control settings to evaluate mRNA therapeutics before release and throughout the research and development process. “This is an example of how advances in laser spectroscopy can directly support modern medicine,” Lednev said. “By better understanding how these therapeutics are formulated, we can help make them safer and more effective.”

This research is a collaborative effort involving Sila Jin and Young Mee Jung of Kangwon National University in South Korea, supported by a training grant from the National Research Foundation of Korea.

The project is part of a new partnership between UAlbany’s Center for Biophotonic Technology and Artificial Intelligence and Kangwon National University’s Institute for Molecular Science and Fusion Technology.